<Disease><Name>HYPERPHOSPHATASIA (JPD)</Name><Synonym>JUVENILE PAGET DISEASE</Synonym><OMIM><Number>239000</Number><URL>http://omim.org/entry/239000</URL></OMIM><Orphanet><Number>2801</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=2801</URL></Orphanet><Protein><Number>Tumor necrosis factor receptor superfamily member 11B</Number><URL>http://www.uniprot.org/uniprot/O00300</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>8q24</Gene><ICD>M88.0, M88.8., M88.9</ICD><Summary>rare ;autosomal recessive ;mutation in the TNFRSF11B gene ;differential diagnosis: - transient hyperphosphatasemia (without clinical or radiological findings) - familial developmental retardation, facial and skeletal abnormalities and hyperphosphatasia (Rabe et al. 1991) therapy with biphosphonate ?</Summary><Symptoms><symtomp><id>2288</id><symptom>bone fractures / pathological fractures</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2414</id><symptom>limb abnormalities, limb deformities / lower limb deformities</symptom><category>SKELETAL DEFECT</category></symtomp><symtomp><id>1787</id><symptom>muscle weakness</symptom><category>MUSCLES</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2358</id><symptom>pain, bones or joints / pain bones</symptom><category>GENERAL TOPICS | SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>1832</id><symptom>short neck</symptom><category>BODY</category></symtomp><symtomp><id>2109</id><symptom>short stature</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2342</id><symptom>skeletal changes, skeletal abnormalities</symptom><category>SKELATAL DEFECT | SKELETAL DEFECT</category></symtomp><symtomp><id>2248</id><symptom>X-ray, abnormalities</symptom><category>LABORATORY FINDINGS</category></symtomp></Symptoms><Metabolites><metabolite><id>1625</id><name>Hydroxyproline</name><specimen>urine</specimen><value>increased</value><min>2.40</min><max>12.50</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>132</id><name>Hydroxyproline</name><specimen>urine</specimen><value>increased</value><min>20.00</min><max>320.00</max><unit>&#956;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1421</id><name>Hydroxyproline</name><specimen>urine</specimen><value>increased</value><min>40.00</min><max>440.00</max><unit>&#956;mol/l</unit><age>all</age><method /><comment /></metabolite><metabolite><id>131</id><name>Hydroxyproline</name><specimen>plasma</specimen><value>increased</value><min>0.00</min><max>91.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1041</id><name>Phosphatase, alkaline</name><specimen>serum</specimen><value>increased</value><min>60.00</min><max>170.00</max><unit>U/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1042</id><name>Phosphatase, alkaline</name><specimen>serum</specimen><value>increased</value><min>20.00</min><max>150.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>2035</id><name>Phosphoethanolamine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>127</id><name>Phosphoethanolamine</name><specimen>plasma</specimen><value>increased</value><min>3.00</min><max>27.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>128</id><name>Phosphoethanolamine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>155.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>451</id><name>Uric acid</name><specimen>urine</specimen><value>increased</value><min>527.00</min><max>790.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1535</id><name>Uric acid</name><specimen>urine</specimen><value>increased</value><min>222.00</min><max>287.00</max><unit>mmol/mol creatinine</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>776</id><name>Uric acid</name><specimen>urine</specimen><value>increased</value><min>820.00</min><max>1026.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>417</id><name>Uric acid</name><specimen>serum</specimen><value>increased</value><min>120.00</min><max>350.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>6630</id><title>Juvenile Paget disease</title><author>Polyzos SA,</author><journal>Metabolism</journal><year>2018</year><book /><volume>80</volume><number>0</number><pages>15-26</pages><co_aut>Cundy T, Mantzoros CS</co_aut></literature><literature><id>6632</id><title>Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease</title><author>Gottesman GS,</author><journal>Am J Med Genet A</journal><year>2016</year><book /><volume>170</volume><number>4</number><pages>978-985</pages><co_aut>et al.</co_aut></literature><literature><id>6631</id><title>Genotype-phenotype correlation in juvenile Paget disease: role of molecular alterations of the TNFRSF11B gene</title><author>Brunetti G,</author><journal>Endocrine</journal><year>2012</year><book /><volume>42</volume><number>2</number><pages>266-271</pages><co_aut>et al.</co_aut></literature><literature><id>2423</id><title>Chronic idiopathic hyperphosphatasia: normalization of bone turnover with cyclical intravenous pamidronate therapy</title><author>Tau C</author><journal>Bone</journal><year>2004</year><book /><volume>35</volume><number>1</number><pages>210-216</pages><co_aut>et al.</co_aut></literature><literature><id>2422</id><title>Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype</title><author>Chong B</author><journal>J Bone Miner Res</journal><year>2003</year><book /><volume>18</volume><number>12</number><pages>2095-2104</pages><co_aut>et al.</co_aut></literature><literature><id>722</id><title>Hereditary hyperphosphatasia: 20 year follow-up and response to sodium etidronate</title><author>Singer F</author><journal>J Bone Miner Res</journal><year>1994</year><book /><volume>9</volume><number>0</number><pages>733-738</pages><co_aut>et al.</co_aut></literature><literature><id>719</id><title>Chronic idiopathic hyperphosphatasia. Report of a case treated with pamidronate and a review of the literature</title><author>Spindler A</author><journal>J Rheumatol</journal><year>1992</year><book /><volume>19</volume><number>4</number><pages>642-645</pages><co_aut>et al.</co_aut></literature><literature><id>717</id><title>Syndrome of developmental retardation, facial and skeletal anomalies, and hyperphosphatasia in two sisters: nosology and genetic</title><author>Rabe P</author><journal>Am J Med Genet</journal><year>1991</year><book /><volume>41</volume><number>0</number><pages>350-354</pages><co_aut>et al.</co_aut></literature><literature><id>720</id><title>Hyperphosphatasia with mental retardation</title><author>Kruse K</author><journal>J Pediatr</journal><year>1988</year><book /><volume>112</volume><number>0</number><pages>436-439</pages><co_aut>et al.</co_aut></literature><literature><id>721</id><title>[Values of total alkaline phosphatase and its isoenzymes in childhood. Transient hyperphosphatasia in children. Presentation of </title><author>Colli R</author><journal>Minerva Pediatr</journal><year>1987</year><book /><volume>39</volume><number>0</number><pages>843-851</pages><co_aut>Frigerio G, Bianchi GA</co_aut></literature><literature><id>724</id><title>[Transient alkaline hyperphosphatemia of childhood. Description of a clinical case]</title><author>Dello-Iacono I</author><journal>Pediatr Med Chir</journal><year>1987</year><book /><volume>9</volume><number>0</number><pages>753-755</pages><co_aut>et al.</co_aut></literature><literature><id>718</id><title>Isolated elevation of serum alkaline phosphatase</title><author>Kruse K</author><journal>Dtsch Med Wochenschr</journal><year>1985</year><book /><volume>110</volume><number>0</number><pages>669-674</pages><co_aut>Kracht U</co_aut></literature><literature><id>723</id><title>Fragile bones and macrocranium</title><author>Bakwin H</author><journal>J Pediatr</journal><year>1956</year><book /><volume>49</volume><number>0</number><pages>558-564</pages><co_aut>Eiger MS</co_aut></literature></Literatures></Disease>